6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine · 1999 · 2.7K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

Simon Lichtiger, D. H. Present, Asher Kornbluth et al. · New England Journal of Medicine · 1994 · 1.7K citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Richard M. Weinshilboum, S. L. Sladek · PubMed · 1980 · 1.2K citations

Veterinary Medicine, Genetics, Pharmacology +13

Treatment of Crohn's Disease with 6-Mercaptopurine

Daniel H. Present, Burton I. Korelitz, Nathaniel Wisch et al. · New England Journal of Medicine · 1980 · 1K citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

Marla C. Dubinsky, Stéphanie Lamothe, Hui Ying Yang et al. · Gastroenterology · 2000 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16